Pharmaceutical Industry Information Portal

HomeNews

News

Recipharm signs Memorandum for the fill finish of vaccines and biotherapeutics in Morocco

The factory, which will be located on a 42 hectare greenfield site is planned to be operational by 2023, will be run by Recipharm and will mirror the company’s new fill finish line at its facility in Monts, France on a larger scale.

WHO recommends life-saving interleukin-6 receptor blockers for COVID-19

Interleukin-6 blocking drugs – tocilizumab and sarilumab – act to suppress this overreaction. WHO has launched an expression of interest for prequalification of manufacturers of interleukin-6 receptor blockers.

RDIF and Morepen Laboratories announce production of the test batch of Sputnik V in India

RDIF and Morepen Laboratories signed a cooperation agreement in June 2021 and are actively implementing the technology transfer.

AGC Biologics Eyeing to Significantly Expand Their Cell and Gene Therapy Capabilities

AGC Biologics announced the signing of a purchase agreement for a state-of-the-art Cell and Gene Therapy commercial manufacturing facility in Longmont, currently owned by Novartis Gene Therapies.

$850 Million investment in FUJIFILM Diosynth Biotechnologies to add additional capacity

Today’s announcement brings the total investments made by Fujifilm in FUJIFILM Diosynth Biotechnologies since 2011 to $5.5B USD (¥600 Billion Yen).

Eleven children receive first dose of Sputnik V in Moscow

After the first and second shots of the vaccine, the teenagers will stay in hospital, in an isolated ward, for three days. Later, they will have to visit the hospital at intervals to undergo tests.
spot_img

Expert Articles

spot_img